Cagrilintide vs semaglutide (Wegovy/Ozempic) Mechanism: Cagrilintide: Amylin receptor agonist Semaglutide: GLP-1 receptor agonist Different pathways Weight loss: Cagrilintide alone: 10-12% Semaglutide alone: 10-15% Similar efficacy monotherapy Gastric emptying: Cagrilintide: Very strong delay Semaglutide: Moderate delay Cagrilintide more powerful Side effects: Cagrilintide: More GI effects (stronger gastric slowing) Semaglutide: Moderate GI effects Cagrilintide harder to tolerate for some Availability: Cagrilintide: Investigational (not approved) Semaglutide: FDA approved, widely available Semaglutide easier to obtain currently Combination potential: Synergistic together (CagriSema) 15-25% weight loss combined Best of both mechanisms Verdict: Similar monotherapy efficacy, but combine for maximum results
Newer medications like Ozempic focus instead on appetite regulation, helping people feel fuller for longer and reducing overall food intake
Administered directly into the bloodstream, vitamin IV therapy delivers essential nutrients, vitamins, and minerals that can enhance energy levels, improve immune function, and support overall well-being
Ask about strategies to preserve lean mass, such as resistance training and protein targets, and discuss a plan for tapering or switching therapy to reduce rebound effects
weakest in Reputation (1.9/5) and Trust & Transparency (2.3/5)
